Literature DB >> 19633819

Characterization of LEF4 ligand binding property and its role as part of baculoviral transcription machinery.

Sheeba Rasheedi1, Madhuri Suragani, Soghra K Haq, Sudip Ghosh, Nasreen Z Ehtesham, Seyed E Hasnain.   

Abstract

Late expression factor 4 (LEF4) is one of the four identified subunits of Autographa californica nucleopolyhedrosis virus (AcNPV) encoded RNA polymerase that carries out transcription from viral late and very late promoters. This 464-amino acid baculovirus-encoded protein also harbors 5' mRNA capping activity that includes RNA 5' triphosphatase, nucleoside triphosphatase, and guanylyltransferase activities. Hydrolysis of 5' triphosphate RNA and free NTPs is metal ion dependent property of the protein. In the present communication, we describe the structural changes in the recombinant LEF4 protein following ligand binding. Metal ion binding causes some alteration in the conformation around aromatic amino acids whereas there is no effect on tryptophan fluorescence on GTP binding in absence and presence of metal ion. It is found that GTP and divalent cation cofactor produce some prominent changes in the secondary structure of the protein. Electrophoretic mobility shift assay (EMSA) shows that LEF4 is the probable factor that acts as anchor to dock the viral RNA polymerase on the very late polyhedrin promoter (Ppolh) facilitated by other factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633819     DOI: 10.1007/s11010-009-0207-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

Review 1.  Structure, mechanism, and evolution of the mRNA capping apparatus.

Authors:  S Shuman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  Roles of LEF-4 and PTP/BVP RNA triphosphatases in processing of baculovirus late mRNAs.

Authors:  Yi Li; Linda A Guarino
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Bifunctionality of the AcMNPV homologous region sequence (hr1): enhancer and ori functions have different sequence requirements.

Authors:  S Habib; S Pandey; U Chatterji; S Burma; R Ahmad; A Jain; S E Hasnain
Journal:  DNA Cell Biol       Date:  1996-09       Impact factor: 3.311

4.  X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes.

Authors:  K Håkansson; A J Doherty; S Shuman; D B Wigley
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

5.  A virus-encoded RNA polymerase purified from baculovirus-infected cells.

Authors:  L A Guarino; B Xu; J Jin; W Dong
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Functional analysis of evolutionary conserved clustering of bZIP binding sites in the baculovirus homologous regions (hrs) suggests a cooperativity between host and viral transcription factors.

Authors:  Igor Landais; Rachel Vincent; Martine Bouton; Gérard Devauchelle; Martine Duonor-Cerutti; Mylène Ogliastro
Journal:  Virology       Date:  2005-09-29       Impact factor: 3.616

7.  The 30-kDa protein binding to the "initiator" of the baculovirus polyhedrin promoter also binds specifically to the coding strand.

Authors:  B Mukherjee; S Burma; S E Hasnain
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

8.  Serine/threonine kinase (pk-1) is a component of Autographa californica multiple nucleopolyhedrovirus (AcMNPV) very late gene transcription complex and it phosphorylates a 102 kDa polypeptide of the complex.

Authors:  Gourav Mishra; Pooja Chadha; Rakha H Das
Journal:  Virus Res       Date:  2008-07-07       Impact factor: 3.303

9.  Biochemical characterization of Sf9 Sp-family-like protein factors reveals interesting features.

Authors:  S Rasheedi; A Ramachandran; N Z Ehtesham; S E Hasnain
Journal:  Arch Virol       Date:  2007-07-27       Impact factor: 2.574

10.  RNA 5'-triphosphatase, nucleoside triphosphatase, and guanylyltransferase activities of baculovirus LEF-4 protein.

Authors:  C H Gross; S Shuman
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.